Multiple Docetaxel Retreatments Without Prednisone for Metastatic Castration-Resistant Prostate Cancer in the Docetaxel-Only Era: Effects on PSA Kinetics and Survival

INTRODUCTION: This study aimed to assess the effects of multiple docetaxel (DOC) treatments on prostate-specific antigen (PSA) kinetics and survival among patients with metastatic castration-resistant prostate cancer (mCRPC) who were sensitive to first-line DOC and received no other life-prolonging...

Descripción completa

Detalles Bibliográficos
Autores principales: Maj-Hes, Agnieszka, Szarvas, Tibor, Sevcenco, Sabina, Kramer, Gero
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8280015/
https://www.ncbi.nlm.nih.gov/pubmed/34043207
http://dx.doi.org/10.1007/s12325-021-01778-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8280015/
https://www.ncbi.nlm.nih.gov/pubmed/34043207
http://dx.doi.org/10.1007/s12325-021-01778-8

Ejemplares similares